indications for glp-1 agonists GLP-1/GIP RA Summary Sheet and Beyond! The science on GLP-1 receptor

Over three years, this translated to roughly 12 fewer serious events in total per 1,000 people using GLP-1 drugs including two fewer deaths

About 4 percent of Americans, roughly 13 million people, are now taking GLP-1 medications like Ozempic and Wegovy for weight loss or diabetes management

Moberly SP, Berwick ZC, Kohr M, Svendsen M, Mather KJ, Tune JD: Intracoronary glucagon-like peptide 1 preferentially augments glucose uptake in ischemic myocardium independent of changes in coronary flow

Improved Blood Sugar Control GLP-1 Agonists help lower blood sugar levels by stimulating insulin release and suppressing glucagon

27 Similarly, a different group (Morningstar Equities) predicts that GLP-1 prices could begin to fall 10%-15% per year beginning in 2027

More significant weight loss typically occurs after 12 to 16 weeks of consistent use